Outpace Bio
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- outpacebio.com
- Total Funding
- $144.0M
- Last Round
- $144.0M Series BAug 2024
About
Outpace Bio is a Seattle-based biotechnology company using AI-powered protein design to develop next-generation cell therapies targeting solid tumors. Its platform combines de novo protein engineering with cellular engineering to improve the efficacy and safety of CAR-T and other cell therapy products. Founded in 2020, the company raised a $144M Series B in 2024.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account